Pediatric Dose Calculator

Children are not simply small adults pharmacokinetically: body water composition, hepatic enzyme maturity, renal clearance, and body-surface-to-volume ratio all differ substantially by age, which is why a flat adult dose scaled down 'by eye' can under- or over-dose a child dangerously. Weight-based mg/kg dosing is the current gold standard because it directly accounts for the child's actual size rather than an age bracket, and it is how essentially all modern pediatric drug labeling, from antibiotics to analgesics to emergency resuscitation drugs, is written. Older proportional rules — Clark's rule (weight in pounds divided by 150, times the adult dose) and Young's rule (age divided by age-plus-12, times the adult dose) — are still taught as a sanity check or a stopgap when weight-based labeling isn't available, but both are approximations that assume a 150 lb adult reference weight and don't account for the actual pharmacokinetic differences in infants versus older children. Body-surface-area (BSA)-based dosing, using the Mosteller formula, is reserved for a narrower set of drugs, chiefly chemotherapy agents, where dosing must scale with metabolic rate and organ perfusion rather than simple body mass. Whatever method is used, the calculated pediatric dose is always checked against — and capped at — the standard adult dose, since a large child's weight-based calculation can occasionally exceed what an adult would receive.

Age- and weight-proportional dosing rules emerged in the late 19th and early 20th centuries as a practical response to the complete absence of pediatric-specific drug trials at the time — nearly every medication was studied only in adults, leaving physicians to improvise scaling methods. Clark's rule, attributed to Cowles Clark in the early 20th century, and Young's rule, published by pediatrician John Young around the same era, were both simple linear approximations designed to be calculated at the bedside without any reference tables. The shift toward true weight-based mg/kg dosing accelerated through the mid-20th century as clinical pharmacology matured and researchers demonstrated that children's drug clearance and volume of distribution scaled much more reliably with body weight (and, for some drugs, body surface area) than with age alone. The 1994 and 1997 U.S. FDA Pediatric Rule and subsequent Best Pharmaceuticals for Children Act (2002) and Pediatric Research Equity Act (2003) mandated pediatric-specific dosing studies for many new drugs, formalizing weight-based dosing as the evidence-backed standard reflected in modern pediatric drug references, while the older proportional rules persisted mainly as teaching tools and emergency approximations.